Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19514829 | 0.88 | FAAH (0.44) | AGTR1FAAHEPHX2MEN1KMT2A | |
| SCHEMBL19514842 | 0.85 | AGTR1 (0.44) | AGTR1FAAHEPHX2MEN1KMT2A | |
| SCHEMBL8669014 | 0.84 | EPHX2 (0.48) | FAAHEPHX2MEN1KMT2AALOX5 | |
| SCHEMBL19287169 | 0.83 | CA12 (0.41) | AGTR1FAAHEPHX2MEN1KMT2A | |
| SCHEMBL7298422 | 0.81 | CPA1 (0.45) | OPRM1OPRD1MEN1KMT2A | |
| SCHEMBL547202 | 0.81 | LMNA (0.49) | MEN1KMT2A | |
| SCHEMBL6045641 | 0.81 | LMNA (0.49) | MEN1KMT2A | |
| SCHEMBL547221 | 0.81 | LMNA (0.49) | MEN1KMT2A | |
| SCHEMBL27422843 | 0.80 | ALOX5 (0.44) | AGTR1OPRM1OPRD1ALOX5LTB4R2 | |
| SCHEMBL27422841 | 0.80 | ALOX5 (0.44) | AGTR1OPRM1OPRD1ALOX5LTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8187579-B2 | Thickening agent | AJINOMOTO CO., INC. (JP) | 2012-05-29 | — | — | US | claimed |
| US-8187579-B2 | Thickening agent | AJINOMOTO CO., INC. (JP) | 2012-05-29 | — | — | US | disclosed |
| US-20090030092-A1 | THICKENING AGENT | AJINOMOTO CO., INC. (JP) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030092-A1 | THICKENING AGENT | CUTA, NAAA, ACOT7 | AGTR1 1685/4885OPRM1 3887/4885OPRD1 3308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.